Department of Anesthesia and Intensive Care, Parma University Hospital, Parma, Italy.
Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
PLoS One. 2020 Sep 30;15(9):e0240014. doi: 10.1371/journal.pone.0240014. eCollection 2020.
Data regarding safety of bedside surgical tracheostomy in novel coronavirus 2019 (COVID-19) mechanically ventilated patients admitted to the intensive care unit (ICU) are lacking. We performed this study to assess the safety of bedside surgical tracheostomy in COVID-19 patients admitted to ICU. This retrospective, single-center, cohort observational study (conducted between February, 23 and April, 30, 2020) was performed in our 45-bed dedicated COVID-19 ICU. Inclusion criteria were: a) age over 18 years; b) confirmed diagnosis of COVID-19 infection (with nasopharyngeal/oropharyngeal swab); c) invasive mechanical ventilation and d) clinical indication for tracheostomy. The objectives of this study were to describe: 1) perioperative complications, 2) perioperative alterations in respiratory gas exchange and 3) occurrence of COVID-19 infection among health-care providers involved into the procedure. A total of 125 COVID-19 patients were admitted to the ICU during the study period. Of those, 66 (53%) underwent tracheostomy. Tracheostomy was performed after a mean of 6.1 (± 2.1) days since ICU admission. Most of tracheostomies (47/66, 71%) were performed by intensivists and the mean time of the procedure was 22 (± 4.4) minutes. No intraprocedural complications was reported. Stoma infection and bleeding were reported in 2 patients and 7 patients, respectively, in the post-procedure period, without significant clinical consequences. The mean PaO2 / FiO2 was significantly lower at the end of tracheostomy (117.6 ± 35.4) then at the beginning (133.4 ± 39.2) or 24 hours before (135.8 ± 51.3) the procedure. However, PaO2/FiO2 progressively increased at 24 hours after tracheostomy (142 ± 50.7). None of the members involved in the tracheotomy procedures developed COVID-19 infection. Bedside surgical tracheostomy appears to be feasible and safe, both for patients and for health care workers, during COVID-19 pandemic in an experienced center.
关于在因 2019 年新型冠状病毒(COVID-19)而接受机械通气的重症监护病房(ICU)患者中进行床边外科气管切开术的安全性的数据尚缺乏。我们进行了这项研究,以评估在 COVID-19 患者中进行床边外科气管切开术的安全性。这项回顾性、单中心、队列观察研究(于 2020 年 2 月 23 日至 4 月 30 日进行)在我们的 45 张专用 COVID-19 ICU 中进行。纳入标准为:a)年龄大于 18 岁;b)通过鼻咽/口咽拭子确诊 COVID-19 感染;c)接受有创机械通气;d)有气管切开术的临床适应证。本研究的目的是描述:1)围手术期并发症,2)围手术期呼吸气体交换的改变,以及 3)参与该过程的医护人员中 COVID-19 感染的发生情况。在研究期间,共有 125 例 COVID-19 患者入住 ICU。其中,66 例(53%)接受了气管切开术。气管切开术在 ICU 入院后平均 6.1(±2.1)天后进行。大多数气管切开术(47/66,71%)由重症监护医生进行,手术平均时间为 22(±4.4)分钟。无术中并发症。术后报告 2 例患者出现造口感染,7 例患者出现出血,但无明显临床后果。气管切开术结束时的 PaO2/FiO2 明显低于开始时(133.4 ± 39.2)或 24 小时前(135.8 ± 51.3),但术后 24 小时后 PaO2/FiO2 逐渐升高(142 ± 50.7)。参与气管切开术的成员均未发生 COVID-19 感染。在经验丰富的中心,COVID-19 大流行期间,床边外科气管切开术对患者和医护人员而言似乎是可行且安全的。